3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
6
Unknown
2
Recruiting
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Frailty
3
Neoplasms
2
Stomach Neoplasms
1
Recurrence
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Myeloid, Acute
1
Dendritic Cell Sarcoma, Interdigitating
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Exercise
18
Drug Therapy
17
pembrolizumab
12
Capecitabine
11
Blood Specimen Collection
11
Surveys and Questionnaires
10
Radiotherapy
10
Dexamethasone
9
Paclitaxel
8
Standard of Care
7
Oxaliplatin
7
Nivolumab
7
Fluorouracil
7
Erlotinib Hydrochloride
7
apatinib
6
Interviews as Topic
6
Gemcitabine
6
Cisplatin
6
Therapeutics
5
Neoadjuvant Therapy
5
Mindfulness-Based Cognitive Therapy
5
Metformin
5
Injections
5
Everolimus
5
Docetaxel
5
Cyclophosphamide
5
Control Groups
5
Bevacizumab
5
sintilimab
4
atezolizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasms
×
Geriatric Assessment
×
Clear all
NCT04686851
2023-12-13
PROGNOSIS-RCT
Odense University Hospital
Phase NA
Unknown
322 enrolled
NCT02671994
2019-01-04
GOAT
Odense University Hospital
Phase NA
Unknown
114 enrolled